Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SL-APO in the Treatment of Patients With Parkinson's Disease: a Real-world Evidence Study to Identify Titration and Usage Schemes - SL-START

NCT07145190 is registered in ClinicalTrials.gov with Bial - Portela C S.A. as lead sponsor.

NCT NCT07145190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07145190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SL-APO in the Treatment of Patients With Parkinson's Disease: a Real-world Evidence Study to Identify Titration and Usage Schemes - SL-START
Lead sponsor
Bial - Portela C S.A.
Phase
Observational
Overall status
Recruiting
Start date
August 27, 2025
Completion date
February 29, 2028
Enrollment
90 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease